effect overlay
activetrials
Active Trials - Other
Huntington's Disease
Skyhawk HD

A Phase I Randomised, Double Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effect of Food on the Bioavailability of SKY-0515 in Healthy Volunteers and Patients with Huntington’s Disease

HREC: 2024.165
Principal Investigator: Prof Dennis Velakoulis
Coordinator contact: Anice Abin & Lei Chen
Funding: Commercial
Active Trials - Other
Peripheral Neuropathy
Argenx BV

A Multicenter Prospective Longitudinal Study of Clinical Outcomes, Disease Course, Health-Related Quality of Life, and Health Care Resource Utilization in Adult Patients With Multifocal Motor Neuropathy (MMN)

HREC: 2024.051
Principal Investigator: Dr Belinda Cruse
Coordinator contact: Callum Hollis
Funding: Commercial
Active Trials - Other
Neurophysiology
Myasthenia Gravis Health Economic Modelling

An investigator-initiated national prospective health economics study to optimise the use of immunoglobulin treatment in adults with Myasthenia Gravis

HREC: 2024.022
Principal Investigator: Dr Belinda Cruse
Coordinator contact:
Funding: Non-Commercial
Active Trials - Other
Huntington's Disease
Generation HD 2

A Phase II, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study to Evaluate the Safety, Biomarkers, and Efficacy of Tominersen in Individuals with Prodromal and Early Manifest Huntington’s Disease
 

HREC: 2023.014
Principal Investigator: Prof Dennis Velakoulis
Coordinator contact: Anice Abin
Funding: Commercial
Active Trials - Other
Neurophysiology
Exteroceptive Reflexes and Healthy Controls

Exteroceptive Reflexes in Neurological Conditions and Healthy Controls
 

HREC: 2022.212
Principal Investigator: Dr Belinda Cruse
Coordinator contact:
Funding: Non-Commercial